UMR Right

UMR Right is a joint research unit affiliated to INSERM (National Institute of Health and Medical Research), EFS (French Blood Bank Institute) and the University of Franche-Comte. We develop basic, translational and clinical research programs to improve knowledge, diagnosis and treatments in the context of cancer immunity and immunotherapy (Team: TIMC), and organ and cell transplantation, inflammatory and autoimmune diseases (Team: ATI). Our main goals: - Characterize the pathogenic or protective immune responses involved in these diseases in order to identify new therapeutic targets and biomarkers - Transfer these advances to the clinic by developing new immunotherapeutic (cell therapies, vaccines,...

Immunology,immunotherapy,cancer,graft,tumor,cell therapy,car-t cells,vaccine,gvhd,transplantation,inflammation,microenvironment,biomarkers,biotherapy,and transplantation

Umr right operates in the Hospitals and health care industry.

Umr right's revenue is 11m - 100m

Umr right has 11 - 50 employees.